What does Dokter Galle Veerle, Hematologie do?

Dokter Galle Veerle, Hematologie is a specialist medical practice in Destelbergen. Private Limited, started on 17 September 2019, 1 establishment.

What is the address of Dokter Galle Veerle, Hematologie?

The registered office of Dokter Galle Veerle, Hematologie is located at Loveldstraat(HEU) 92, 9070 Destelbergen.

Is Dokter Galle Veerle, Hematologie still active?

Yes. According to the CBE (17 September 2026) Dokter Galle Veerle, Hematologie is active, legal situation “Normale toestand”, started on 17 September 2019.

Is Dokter Galle Veerle, Hematologie registered on Peppol?

Yes, Dokter Galle Veerle, Hematologie is registered on the Peppol network with ID 0208:0734556947.

What is the enterprise number of Dokter Galle Veerle, Hematologie?

The enterprise number of Dokter Galle Veerle, Hematologie is BE0734556947.

When was Dokter Galle Veerle, Hematologie founded?

Dokter Galle Veerle, Hematologie was founded on 17 September 2019.

Who are the directors of Dokter Galle Veerle, Hematologie?

According to the 2025 annual accounts, the directors of Dokter Galle Veerle, Hematologie are: VEERLE GALLE.

Is Dokter Galle Veerle, Hematologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 September 2019; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dokter Galle Veerle, Hematologie make in 2025?

Dokter Galle Veerle, Hematologie posted a profit after taxes of € 176,320 in financial year 2025.

What is the revenue of Dokter Galle Veerle, Hematologie?

As a small company, Dokter Galle Veerle, Hematologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 277,518.

Dokter Galle Veerle, Hematologie (Private Limited)

Dossier Dokter Galle Veerle, Hematologie, printed on 17 September 2026 from databakkes.be/en/0734556947/dokter-galle-veerle-hematologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2023.

Financials

Financial year 2025

Dokter Galle Veerle, Hematologie from Destelbergen, company number BE0734556947, closed financial year 2025 with a result of € 176,320 after tax. For that financial year Dokter Galle Veerle, Hematologie recorded a gross margin of € 277,518 and equity of € 707,725. Compared with financial year 2024, the result moved from € 158,631 to € 176,320. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 28, 2026.

What it is worth Growing

€ 707,725

▲ 33% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 176,320

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 186,003

▼ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 702,725.

People and assets in 2025

Vehicles and equipment

€ 28,366

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 274,617

€ 42,710 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 7,846

▲ 40% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 10,133

▲ 21% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 226,308 Gross margin 2022: € 226,308 First fiscal year in the series	€ 270,281 Gross margin 2023: € 270,281 ▲ 19% vs 2022 (€ 226,308) Favourable step	€ 258,256 Gross margin 2024: € 258,256 ▼ 4% vs 2023 (€ 270,281) Unfavourable step	€ 277,518 Gross margin 2025: € 277,518 ▲ 7% vs 2024 (€ 258,256) Favourable step	▲ 7%
Profit after taxes	€ 143,938 Profit after taxes 2022: € 143,938 First fiscal year in the series	€ 180,401 Profit after taxes 2023: € 180,401 ▲ 25% vs 2022 (€ 143,938) Favourable step	€ 158,631 Profit after taxes 2024: € 158,631 ▼ 12% vs 2023 (€ 180,401) Unfavourable step	€ 176,320 Profit after taxes 2025: € 176,320 ▲ 11% vs 2024 (€ 158,631) Favourable step	▲ 11%
Equity	€ 317,374 Equity 2022: € 317,374 First fiscal year in the series	€ 372,774 Equity 2023: € 372,774 ▲ 17% vs 2022 (€ 317,374) Favourable step	€ 531,405 Equity 2024: € 531,405 ▲ 43% vs 2023 (€ 372,774) Favourable step	€ 707,725 Equity 2025: € 707,725 ▲ 33% vs 2024 (€ 531,405) Favourable step	▲ 33%
Total debts	€ 423,705 Total debts 2022: € 423,705 First fiscal year in the series	€ 352,769 Total debts 2023: € 352,769 ▼ 17% vs 2022 (€ 423,705) Favourable step	€ 289,748 Total debts 2024: € 289,748 ▼ 18% vs 2023 (€ 352,769) Favourable step	€ 292,596 Total debts 2025: € 292,596 ▲ 1% vs 2024 (€ 289,748) Unfavourable step	▲ 1%
Cash	€ 342,573 Cash 2022: € 342,573 First fiscal year in the series	€ 121,369 Cash 2023: € 121,369 ▼ 65% vs 2022 (€ 342,573) Unfavourable step	€ 217,367 Cash 2024: € 217,367 ▲ 79% vs 2023 (€ 121,369) Favourable step	€ 186,003 Cash 2025: € 186,003 ▼ 14% vs 2024 (€ 217,367) Unfavourable step	▼ 14%
Land & buildings	€ 364,359 Land & buildings 2022: € 364,359 First fiscal year in the series	€ 417,213 Land & buildings 2023: € 417,213 ▲ 15% vs 2022 (€ 364,359) Unchanged	€ 424,000 Land & buildings 2024: € 424,000 ▲ 2% vs 2023 (€ 417,213) Unchanged	€ 413,816 Land & buildings 2025: € 413,816 ▼ 2% vs 2024 (€ 424,000) Unchanged	▼ 2%
Retained profit	€ 312,374 Retained profit 2022: € 312,374 First fiscal year in the series	€ 367,774 Retained profit 2023: € 367,774 ▲ 18% vs 2022 (€ 312,374) Favourable step	€ 526,405 Retained profit 2024: € 526,405 ▲ 43% vs 2023 (€ 367,774) Favourable step	€ 702,725 Retained profit 2025: € 702,725 ▲ 33% vs 2024 (€ 526,405) Favourable step	▲ 33%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 125,000 Dividend 2023: € 125,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 125,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 318,783 Bank debt 2022: € 318,783 First fiscal year in the series	€ 347,519 Bank debt 2023: € 347,519 ▲ 9% vs 2022 (€ 318,783) Unfavourable step	€ 275,750 Bank debt 2024: € 275,750 ▼ 21% vs 2023 (€ 347,519) Favourable step	€ 274,617 Bank debt 2025: € 274,617 Unchanged (€ 275,750) Favourable step
Balance sheet total	€ 741,079 Balance sheet total 2022: € 741,079 First fiscal year in the series	€ 725,543 Balance sheet total 2023: € 725,543 ▼ 2% vs 2022 (€ 741,079) Unchanged	€ 821,153 Balance sheet total 2024: € 821,153 ▲ 13% vs 2023 (€ 725,543) Unchanged	€ 1,000,321 Balance sheet total 2025: € 1,000,321 ▲ 22% vs 2024 (€ 821,153) Unchanged	▲ 22%

Key figures of Dokter Galle Veerle, Hematologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Dokter Galle Veerle, Hematologie?

What happened at Dokter Galle Veerle, Hematologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 28, 2026 New annual accounts for financial year 2025: profit of € 176,320 (▲ 11% vs 2024). filed late Source: NBB ↗
Sep 17, 2019 New establishment in Destelbergen. KBO
Sep 17, 2019 Start of the company according to the CBE. KBO

In short

From € 143,938 profit in 2022 to € 176,320 profit in 2025.

Paid € 268,465 in corporate taxes since 2022.

Best year ever: 2023, with € 180,401 profit.

Paid out € 125,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dokter Galle Veerle, Hematologie? We notify you, reason included.

Follow Dokter Galle Veerle, Hematologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

VEERLE GALLE

Dokter Galle Veerle, Hematologie

Behind Dokter Galle Veerle, Hematologie is VEERLE GALLE.

See the full network in the app

Directors

According to the 2025 annual accounts

VEERLE GALLE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Loveldstraat(HEU) 92

9070 Destelbergen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0734.556.947

VAT number

BE 0734.556.947

Registered office

Loveldstraat(HEU) 92, 9070 Destelbergen

Names & denominations

Dokter Galle Veerle, Hematologie

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 September 2019

Peppol

Active · Active since 24 Sept 2025

Activities · NACE

Activiteiten van medisch specialisten

Overige vormen van onderwijs

View on CBE Public ↗ Annual accounts (NBB) ↗

Dokter Galle Veerle, Hematologie

Warning lights

Financials

What happened to Dokter Galle Veerle, Hematologie?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions